CRYOPORT, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CRYOPORT, INC. stock issued during period, shares, new issues for the quarter ending 2014-12-31 was 107.98K shares.
- CRYOPORT, INC. stock issued during period, shares, new issues for the quarter ending 2014-09-30 was 84.50K shares.
- CRYOPORT, INC. stock issued during period, shares, new issues for the quarter ending 2014-06-30 was 86.80K shares.
- CRYOPORT, INC. stock issued during period, shares, new issues for fiscal 2019 was 248.84K shares, a 0.00% change from fiscal 2018.
- CRYOPORT, INC. stock issued during period, shares, new issues for fiscal 2018 was 248.84K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2019-12-31 | 248.84K shares 10-K · filed 2020-03-10 | |
| 2018-12-31 | 248.84K shares 10-K · filed 2019-03-13 | |
| 2014-12-31 | 107.98K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05 | |
| 2014-09-30 | 84.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-12 | |
| 2014-06-30 | 86.80K shares 10-Q · filed 2014-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |